Drupal.behaviors.print = function(context) {window.print();window.close();}>
Using Myriad as Case Study, Paper Urges Europe to Ensure Greater Access to Genetic Test Data
October 31, 2012
Using Myriad as Case Study, Paper Urges Europe to Ensure Greater Access to Genetic Test Data
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Australia Federal Court Dismisses Cancer Patients' Challenge to Myriad's Gene Patent
February 15, 2013 / GenomeWeb Daily News
UK's NICE Seeks Comments on Updated Guidelines for Familial Breast Cancer Genetic Testing, Treatment
January 23, 2013 / Pharmacogenomics Reporter
Policy Experts Say Myriad's Proprietary Variant Database Sets Bad Precedent for Personalized Medicine
November 2, 2012 / Pharmacogenomics Reporter
ACLU Files for Second Supreme Court Review of Myriad's Gene Patents
September 25, 2012 / GenomeWeb Daily News
Appeals Court Affirms Isolated DNA Patents in Myriad Case
August 16, 2012 / GenomeWeb Daily News